Verde Science Inc (VRCI) 0.0580 $VRCI Verde Science

New Post Public Reply Private Reply Replies (0) Message Board

Oct 10, 2015 at 11:02 AM

Verde Science Inc (VRCI) 0.0580 $VRCI

Verde Science Announces Plan to Study Cannabis Preparation for Treatment of Huntingdon's Disease
GlobeNewswire - Fri Oct 09, 12:15PM CDT
Verde Science, Inc. (OTCQB:VRCI), a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients' needs for a wide range of medical conditions, is pleased to announce that along with some renowned research scientists it intends to study the treatment potential of a cannabis preparation (Nabiximols) in the treatment of Huntingdon's Disease as a sponsor at 2 universities in North America. The study as currently designed will be a double-blind, placebo controlled protocol with 48 subjects.

Verde Science Appoints International Banker Manfred A. Schauer
ACCESSWIRE - Mon Jun 01, 7:01AM CDT
LAS VEGAS, NV / ACCESSWIRE / June 1, 2015 / (PINKSHEETS:VRCI) Verde Science Inc., a pharmaceutical research and development company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients needs for a wide range of medical conditions, is pleased to announce the appointment of Manfred Schauer as head of the Asia Pacific Region.
DB: 29.34 (+0.95)

Verde Science Adds Lawyer, Bradley J. Dixon, J.D. to Board
ACCESSWIRE - Wed May 20, 1:29PM CDT
LAS VEGAS, NV / ACCESSWIRE / May 20, 2015 / Verde Science, Inc. (OTCPK: VRCI), a Pharmaceutical Research and Development Company focused on developing effective treatments for contemporary health issues, with an initial focus on developing cannabinoid-based prescription medicines is pleased to announce the appointment of Bradley J. Dixon, J.D. to its Board of Directors. Mr. Dixon is a partner with the firm of Stoel Rives, LLP, which has offices throughout the Northwest and California. His professional honors include selection as one of America's Leading Lawyers for Business by Chambers USA, listing in Mountain States Super Lawyers, and admission to the Order of Barristers. Mr. Dixon's areas of practice include Business Law, Government Affairs, Commercial Litigation, and Labor and Employment Law.

Verde Science Appoints New Chief Financial Officer with Pharmaceutical Sector Experience
ACCESSWIRE - Tue May 12, 5:00AM CDT
LAS VEGAS, NV / ACCESSWIRE / May 12, 2015 / PINKSHEETS: VRCI Verde Science, Inc., a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients' needs for a wide range of medical conditions is pleased to announce the appointment of David Alexander, CA as its new CFO, effective immediately. David graduated with BComm in Finance from the University of British Columbia. He has managed the rapid growth of several early stage and startup companies. As CFO of Arakis Energy Corporation, an international oil and gas development company, he managed its growth from startup to over a billion dollars in assets, and listed it on Nasdaq. Arakis was subsequently sold to Talisman Energy Inc. He was also CFO of Nortran Pharmaceuticals, Inc., a University of British Colombia based pharmaceutical Research and Development Company engaged in the development and commercialization of cardiovascular therapies. While at Nortran, David helped secure initial and ongoing research financing. Nortran subsequently, became into Cardiome Pharma Corp., a successful Vancouver BC based pharmaceutical company (Nasdaq: CRME).
CRME: 8.53 (+0.40), TLM: 7.99 (unch)

Verde Science Adds John M. E. Percival to the Head of Strategic Development and Member of Board of Directors
ACCESSWIRE - Mon May 04, 5:04AM CDT
LAS VEGAS, NV / ACCESSWIRE / May 4, 2015 / (PINKSHEETS: VRCI) Verde Science, Inc. a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients needs for a wide range of medical conditions is pleased to announce the appointment of John M. E. Percival to its Board of Directors and Head of Strategic Business Development. Mr. Percival brings over 20 years of Investment Banking, Corporate Finance and Strategic planning success to Verde. Mr. Percival was previously General Manager of Investments at Barclays Bank New Zealand, Ltd where he was responsible for the management of nearly a $500 million in Superannuation and private funds.

Reviews Of 15 Marijuana Stocks Before The Marijuana Investor Summit - Part X
Anthony Cataldo - at Seeking Alpha - Tue Apr 21, 6:30AM CDT

XXII: 1.08 (unch), VPCO: 0.58 (+0.02)

Verde Science adds Shantesh Hede, Ph.D As Director of Product Development
ACCESSWIRE - Fri Apr 10, 7:15AM CDT
LAS VEGAS, NV / ACCESSWIRE / April 10, 2015 / (PINKSHEETS:VRCI) Verde Science, Inc., a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients needs for a wide range of medical conditions, is pleased to announce the addition of Shantesh Hede, Ph.D. as Director of Product Development. Dr. Hede will be based in Mumbai, India and will direct Verde Science's R&D programs on-site with Verde's Research and Development partner, the Institute of Chemical Technology. He earned a Ph.D. in Bioengineering Systems from the MIT Portugal Program, a Master of Engineering Management from Duke University, and a Bachelors in Pharmaceutical Sciences from the Institute of Chemical Technology.

Verde Science Signs Research and Development Pact with Institute Of Chemical Technology
ACCESSWIRE - Wed Apr 08, 6:15PM CDT
LAS VEGAS, NV / ACCESSWIRE / April 8, 2015 / (PINKSHEETS: VRCI) Verde Science, Inc., a Pharmaceutical Research and Development Company focused on developing a portfolio of cannabinoid based prescription medicines to meet patients needs for a wide range of medical conditions, is pleased to announce the execution of a definitive Research and Development Agreement with the Institute of Chemical Technology of Mumbai, India. Under the terms of the agreement Verde Science researchers and faculty and staff of the University will cooperate on original research with the goal of identifying and developing novel pharmaceutical formulations derived from the marijuana plant for the treatment of specific medical issues.

Verde Science Investor Update
ACCESSWIRE - Fri Mar 13, 8:00AM CDT
LAS VEGAS, NV / ACCESSWIRE / March 13, 2015 / Verde Science, Inc., (PINKSHEETS:VRCI) a Medical Research and Development Company focused on developing effective treatments for emerging and contemporary health issues, with an initial focus on Medical Marijuana is pleased to update shareholders and investors regarding significant developments in the Medical Marijuana R&D arena.

53 Marijuana Stocks - A Post-Mortem: Part III And Epilogue
Anthony Cataldo - at Seeking Alpha - Thu Mar 05, 2:25PM CST

VPCO: 0.58 (+0.02)

12 More Marijuana Stocks To Avoid - Part II
Anthony Cataldo - at Seeking Alpha - Thu Feb 19, 8:37AM CST

News Release Verde Science Pursuing Development of Promising Point-Of-Care Ebola Screening Test
ACCESSWIRE - Mon Nov 10, 8:08AM CST
Image: https://www.baystreet.ca/uploads/verde.jpg

Verde Science and Sterkem Group Sign Pharmaceutical Development Agreement
ACCESSWIRE - Thu Nov 06, 8:01AM CST
Image: https://www.baystreet.ca/uploads/eyukuVRCI.png

News Release Verde Science R
ACCESSWIRE - Tue Nov 04, 5:00AM CST
Verde Science R&D Team Ready To Move Forward With Design Of Research Plan

Verde Science Appoints Chief Technology Officer
ACCESSWIRE - Wed Oct 22, 8:03AM CDT
Image: https://www.baystreet.ca/uploads/Verde-Scienc...-Logo1.png

Verde Science Strengthens Scientific Team
ACCESSWIRE - Thu Oct 02, 8:01AM CDT
Image: https://www.baystreet.ca/uploads/Verde-Scienc...-Logo1.png

ID Global Corporation Seeks Strategic Partnership with Verde Science, Inc.
PR Newswire - Wed Oct 01, 9:47AM CDT
ID Global Corp. (OTC: IDGC) is pleased to announce that it has signed a binding Memorandum of Understanding (MOU) with Verde Science, Inc. (OTCBB:VRCI), a Medical Marijuana Research and Development Company with particular expertise in Aeroponic Growing Systems, to begin due-diligence towards a joint venture (Exclusive or non-exclusive) whereby IDGC will provide assistance in raising capital, business advisory services and/or merger discussions.

Verde Science Forms R and D Alliance
ACCESSWIRE - Tue Sep 23, 10:14AM CDT
Richmond, BC / ACCESSWIRE / September 23, 2014 / Verde Science, Inc., (OTCQB: VRCI) a Medical Marijuana Research and Development Company with particular expertise in Aeroponic Growing Systems for the production of pure, efficacious Medical Marajuana, is pleased to announce a Research and Development Alliance with a Mumbai, India based pharmaceutical company that has a record of significant success in the development of novel medical treatment compounds. This new relationship will allow Verde to launch immediately on its THC Pharmaceutical Development Program, and accelerate its R and D operations by about one year. Without this important alliance Verde would have experienced unnecessary delays as it waited for its Research and Development License in Canada. According to Harp Sangha, Verde's Chairman and CEO, "Now we can immediately access the vast treasure of our Indian partner's intellectual capital and tap into a highly educated organization of research scientists in a cost effective manner."

Verde Science to Present at Aegis Capital Conference
Newsfile Corp - Thu Sep 11, 11:08AM CDT
full story)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Picturing Grief: Scoville's Visual Journey in Loss

Let Images Speak the Unspeakable So, here's the deal: grief isn't something you can just wrap up in a neat little package of words. It's jagged, messy—and for many, untouchable by a traditional self-help roadmap. Enter Picturing Grief, the book by Michelle Scoville that smashes the mold with its arresting mix of imagery and reflection. Freshly on the scene courtesy of...

Anguilla: Paradise for Safe, Solo Beach Escapes

A Safe Haven for Solo Adventurers You ever dream of escaping to a place where the world slows down and serenity reigns supreme? Somewhere you can kick back, soak up the sun, listen to the waves, and leave your worries behind? Well, folks, Tranquility Beach Anguilla fits that bill and then some. Why Anguilla Tops the List Let's talk about the accolades Anguilla has raked...

wagamama Spruces Up U.S. Market with mamago Launch

What's Cooking at wagamama with mamago? Here comes wagamama, striding into the American dining scene with that familiar bold Pan-Asian flair, now offering more than just a seat at their tables. The fresh move to a direct-to-door model dubbed ‘mamago’ ushers in an era where their signature dishes don't just seduce your taste buds at their restaurants. Nope, they are...

ACCULOAD: Aiming for Safer, Easier Boat Loading

Getting a boat onto a trailer? It can turn into a circus act if you're not careful. Visibility's shot, conditions change faster than a stock ticker, and alignment's like threading a needle blindfolded. Out comes ACCULOAD, a novel idea created by some intrepid inventor down in Slocomb, Ala, aiming to solve what’s been a pain point for boaters worldwide. What's ACCULOAD...

Solink Secures $100M: NYSE Sees Tech and Sports Moves

Folks, it’s a busy day on Wall Street, with Solink leading the charge by landing over a cool $100 million in fresh funding. Let's break this down because when startups pocket nine-digit figures, it's time to pay attention. Solink's Leap Forward Now, what’s Solink doing with all that cash? They're not scrambling for coffee money, that's for sure. Instead, this funding...

Abel Leads PRSA Maryland Chesapeake as New Chapter President

New Leadership and Opportunities in the PR Landscape Amid all the hustle and bustle of the corporate world, something big's brewing in Baltimore's public relations sphere. Greg Abel, the go-getting mastermind behind Abel Communications, has taken the helm of the newly formed PRSA Maryland Chesapeake chapter. This isn't just about shifting chairs or fancy titles—this...

$4 Million Raised at Miracles for Kids Gala 2026

Anthony Geisler's Impactful Philanthropy Ever heard that old chestnut about putting your money where your mouth is? Well, Anthony Geisler, the chap behind Sequel Brands, sure seems to embody it. At the 2026 Miracles for Kids Night of Miracles Gala, he managed to corral over $4 million for families with critically ill kids. That's no chump change, let me tell you. The...

Modular Building Boom Shakes Up Asian Construction

Building the Future, One Module at a Time What's ticking in the world of construction? Modular buildings, my friends. They're generating buzz at the Fourth Linyi Mall International Buyers Conference held last week, and for good reasons. If you're not following, China is rolling out prefabricated houses like they're the next big thing since sliced bread, leaving buyers in...

Dermatology Access Expands in Kansas With Expert Return

Jenna King's Return Elevates Local Care Who says you can't go home again? Jenna King, a familiar face in Southeast Kansas, is back to serve her community by upping the ante in dermatology care at U.S. Dermatology Partners in Pittsburg. After gaining experience in Oklahoma, she's here to extend both medical and cosmetic treatments to her neighbors. Why Her Return Is a Game...

HIZENERGY Rolls Out Power-Packed BESS for Europe

Powering Europe's Energy Shift with HIZENERGY Ever felt like you're lost in the frenzy of Europe's energy transition? Well, HIZENERGY is diving headfirst into the chaos with their spiffy Commercial & Industrial Battery Energy Storage Systems (C&I BESS). Amid Europe's hunt for grid stability—with whiplash-inducing solar adoption and electricity pricing that behaves like...